期刊文献+

西酞普兰合用利培酮治疗强迫症临床分析 被引量:2

下载PDF
导出
摘要 目的:探讨西酞普兰合用利培酮治疗强迫症的疗效及不良反应。方法:将37例强迫症患者随机分为西酞普兰合用利培酮组和西酞普兰单用组,治疗8周。采用强迫症量表(YBOCS)、汉密尔顿抑郁量表(HAMD)、副反应量表(TESS)评定疗效和不良反应。结果:治疗结束时,两组YBOCS、HAMD的评分均显著降低,合用组更明显。两组间TESS评分比较无显著差异。结论:西酞普兰合用利培酮治疗强迫症可提高疗效。
出处 《临床精神医学杂志》 2005年第3期167-167,共1页 Journal of Clinical Psychiatry
  • 相关文献

参考文献4

二级参考文献45

  • 1Ravizza 郭卫刚(译).强迫症药物疗效的预测[J].国外医学:精神病学分册,1996,23(2):116-116.
  • 2中华医学会精神科学会 南京医科大学脑科医院.中国精神疾病分类方案与诊断标准第二版修订本(CCMD-2-R)[M].南京:东南大学出版社,1994.80-81.
  • 3Wayne K Goodman MD.强迫障碍的诊断与治疗[J].精神医学论坛,2000,2(1):37-41.
  • 4加藤佳彦 雷声(译).强迫障碍的转归[J].国外医学:精神病学分册,1996,23(4):254-254.
  • 5[1]Mendels J, Kiev A, Fabre L. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia. Depress Anxiety,1999,9(2) :54~60.
  • 6[2]Leinonen E, Skarstein J, Behnke K, et al. Efficacy and tolerability of mitazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant study group. Int Clin Psychopharmacol, 1999,14(6) :37~329.
  • 7[3]Ekselius L,Von Knorring L,Eberhard G. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psyc hopharmacol, 1997,12 (6): 31~323.
  • 8[4]Patris M, Bouchard J, Bougerol T, et al. Citalopram versus fluoxetine: a double-blind,controlled,muticentre,phase Ⅲ trial in patients with unipolar major depression treated in general practice. Int Clin Psychopharmacology, 1996,11 (2): 36~129.
  • 9[5]Rosenberg C,Damsbo N,Fuglun E,et al. Citaloprarn and imipramine in the treatment of depressive patients in general practice. A nordic multicentre clinical study. Int Clin Psychopharmacol, 1994, 9 (Suppl 1): 8~41.
  • 10[6]Robert P, Montgomery S. A 24-week study of 20mg citalopram, 40mg citalopram,and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol, 1993,8 (3): 8~181.

共引文献19

同被引文献15

  • 1司天梅,舒良.关于新抗抑郁药艾司西酞普兰[J].临床精神医学杂志,2007,17(1):68-69. 被引量:124
  • 2Murdoch D ,Keam SJ. Escitalopram: a review of its use in the management of major depressive disorder[J]. Drugs, 2005,65 : 2 379-2 404.
  • 3向虎,杜海英,郑崇芬.国产氟西汀治疗强迫症的对照研究[J].临床精神医学杂志,1997,7(1):34-35. 被引量:17
  • 4沈渔邨.精神病学[M]北京:人民卫生出版社,2009602-605.
  • 5Husted D S,Shapira N A. A review of the treatment for refractory obsessive-compulsive:From medicine to deep brain stimulation[J].CNS S Peetr,2004.833-847.
  • 6Anat A,Alzbeta J W,Joseph Z. Pharmacological management of treatment-resistant obsessive-compulsive disorder[J].CNS DRUGS,2011,(07):585-596.
  • 7Dold M,Aigner M,Lanzenberger R. Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder:A meta-analysis of double-blind,randomised,placebocontrolled trials[J].Fortschritte der Neurologie Psychiatrie,2011,(08):453-466.
  • 8US FDA. FDA approves new drug for schizophrenia[EB/OL].http://www.fda.gov/bbs/topics/ NEWS/2006/ NEW01534.html,2007.
  • 9中华医学会精神科分会.中国精神障碍分类与诊断标准[M]济南:山东科学技术出版社,2001107-108.
  • 10喻东山.精神科合理用药手册[M]南京:江苏科学技术出版社,2006246-047.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部